等待開盤 09-27 09:30:00 美东时间
-0.720
-10.79%
Stock index futures rose on Friday as discussions on rate cuts continued to be in focus, amid the release of a key inflation gauge. This was after Wall Street finished lower in a roller coaster sessi...
09-26 21:15
Rezolve AI (NASDAQ:RZLV) announced it has signed agreements with two existing institutional investors for an oversubscribed $200 million private placement (before fees and expenses). The deal is expec...
09-24 20:19
Rezolve Ai announced a $200 million private placement with institutional investors, closing on September 25, 2025. Proceeds will support sales growth, M&A opportunities, working capital, and corporate initiatives. A.G.P. and H.C. Wainwright & Co. are leading the placement.
09-24 12:00
Rezolve Ai的CEO Daniel M. Wagner将参与2025年9月24日举行的第三届Roth AI峰会虚拟炉边聊天。Rezolve Ai是一家领先的AI解决方案公司,致力于通过AI提升客户互动、运营效率和收入增长。更多信息请联系Roth代表或访问提供的链接。
09-23 12:00
Rezolve Ai announced the expiration or exercise of all private placement warrants issued in December 2024, eliminating market overhang and boosting investor confidence. This clears the capital structure, allowing focus on growth and value creation.
09-18 12:00
Rezolve Ai (NASDAQ: RZLV), a leader in AI-powered commerce solutions and a strategic partner of Microsoft and Google, has emphasized its strategy to avoid common pitfalls in the AI industry, such as miscalculating scale and expenditures. The company attributes its success to strong leadership, proprietary AI technology, and disciplined execution. Rezolve believes its approach provides lower risk, greater predictability, and significant opportunit...
09-17 12:00
Rezolve Ai appoints Crispin Lowery as EVP of Growth to drive global expansion of its AI commerce platform. Lowery, formerly at Microsoft and Google, will lead the adoption of Brain Commerce, targeting the $30 trillion retail market. Rezolve has achieved milestones including Visual Search, Crypto Wallet with USAT stablecoin, and inclusion in Russell indices. Projections expect ARR to surpass $100 million by year-end, with Lowery’s expertise set to...
09-16 12:00
今日重点评级关注:Benchmark:维持Unicycive Therapeutics"投机性买入"评级,目标价从3美元升至21美元;Guggenheim:维持Amylyx Pharmaceuticals"买入"评级,目标价从17美元升至25美元
09-16 09:48
U.S. stocks were higher, with the Nasdaq Composite gaining more than 100 points...
09-16 02:58
There’s a lot to be optimistic about in the Financial sector as 2 analysts just...
09-15 18:20